Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03687372 · ClinicalTrials.gov registry record · Phase 3
Study of A-101 Topical Solution for the Treatment of Common Warts
A Phase 3 study, sponsored by Aclaris Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 503
- Enrollment target
NCT03687372 is a Phase 3 study that has completed, run by Aclaris Therapeutics. The registered enrollment target is 503 participants.
The verdict
NCT03687372, a Phase 3 study, has completed, sponsored by Aclaris Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 503 participants
- Enrollment target
Study Summary
A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts
Interventions
- DRUG A-101
- OTHER vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 503 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2019-09-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03687372
The ClinicalTrials.gov registry entry for NCT03687372 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 503 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aclaris Therapeutics, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which A-101 is the first listed.
NCT03687372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03687372 about?
NCT03687372 is a clinical study titled "Study of A-101 Topical Solution for the Treatment of Common Warts". A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts
What is the current status of trial NCT03687372?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 503 participants. The study started on 2018-09-17. Estimated completion is 2019-09-06.
What interventions are being tested in trial NCT03687372?
The interventions under investigation include: A-101 (DRUG), vehicle (OTHER).
Who is sponsoring clinical trial NCT03687372?
This trial is sponsored by Aclaris Therapeutics, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.